Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
General Internal Medicine
•
Nephrology
•
Nephrolithiasis
Do you recommend checking 1,25-hydroxy vitamin D levels in patients with recurrent nephrolithiasis who have hypercalciuria of unknown etiology?
Answer from: at Academic Institution
No, unless they are hypercalcemic or I suspect renal sarcoidosis. Stephen B Erickson, MD
Sign In
or
Register
to read more
Answer from: at Community Practice
It depends on the degree of the hypercalciuria and whether they also have hypercalcemia and what their PTH concentration is.
Sign In
or
Register
to read more
Answer from: at Community Practice
No, unless I’m concerned there may be a granulomatous process that is concerting (i.e. sarcoid, lymphoma) as a high 1,25 OH vitamins D in the context of persistent hypercalciuria and recurrent stones may inform my management decision.
Sign In
or
Register
to read more
24906
24932
25029
Related Questions
Do you recommend any specific testing for patients with recurrent nephrolithiasis and suspected absorptive hypercalciuria?
Would you recommend initiation of cinacalcet in a patient with hypercalcemia and recurrent nephrolithiasis attributed to an atypical presentation of familial hypocalciuric hypercalcemia?
Is there a BMI cutoff for which you would refer a patient needing a native kidney biopsy to interventional radiology?
What is your approach to the diagnosis of acute kidney injury suspected secondary to renal infarction from thromboembolic disease?
Do you avoid potassium citrate in patients with recurrent nephrolithiasis and hypocitraturia if they also take antihistamine medications?
Would you refer a patient for kidney only or kidney and liver transplantation if they develop advanced chronic kidney disease secondary to primary hyperoxaluria type 2?
What is your approach to IV fluid management for the treatment of hypercalcemia of malignancy?
How do you use NT-proBNP in patients with chronic kidney disease or end-stage kidney disease, given that these conditions can affect NT-proBNP levels?
What is your approach to bisphosphonate use in patients with advanced chronic kidney disease and osteoporosis?
Do you recommend holding ACE inhibitors, ARBs, and SGLT2 inhibitors for patients with chronic kidney disease and malignancy who are about to start high-dose intravenous methotrexate?